The Board of Directors of Guangzhou Wondfo Biotech Co.,Ltd has authorized a buyback plan on September 26, 2022.
Guangzhou Wondfo Biotech Co.,Ltd
Equities
300482
CNE100002102
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
24.57 CNY | -2.50% |
|
-0.73% | -18.56% |
06-17 | Guangzhou Wondfo Biotech Co.,Ltd Announces Board Changes | CI |
05-29 | Guangzhou Wondfo Biotech Co.,Ltd Announces Final Cash Dividend (A Shares) for Year 2023, Payable on June 5, 2024 | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.56% | 1.59B | |
-7.06% | 12.28B | |
+97.25% | 8.54B | |
-22.31% | 6.58B | |
+8.16% | 5.77B | |
-23.82% | 3.48B | |
+5.84% | 2.54B | |
+42.74% | 2.41B | |
-7.50% | 2.3B | |
-68.08% | 2.07B |
- Stock Market
- Equities
- 300482 Stock
- News Guangzhou Wondfo Biotech Co.,Ltd
- Guangzhou Wondfo Biotech Co.,Ltd authorizes a Buyback Plan.